Australia and Oceania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Australia and Oceania

In 2022, the prophylactic medicaments containing insulin market in Australia and Oceania was finally on the rise to reach $X for the first time since 2019, thus ending a two-year declining trend. The market value increased at an average annual rate of +2.0% from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations in certain years. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Australia and Oceania

In value terms, prophylactic medicaments containing insulin production rose slightly to $X in 2022 estimated in export price. The total production indicated a buoyant expansion from 2012 to 2022: its value increased at an average annual rate of +6.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -3.3% against 2020 indices. The growth pace was the most rapid in 2014 with an increase of 39%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Australia and Oceania

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported in Australia and Oceania reduced markedly to X tons, which is down by -57.2% on the previous year's figure. In general, exports showed a pronounced descent. The pace of growth was the most pronounced in 2021 when exports increased by 233% against the previous year. Over the period under review, the exports hit record highs at X tons in 2014; however, from 2015 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports declined to $X in 2022. Overall, exports showed a pronounced decrease. The growth pace was the most rapid in 2018 with an increase of 108% against the previous year. As a result, the exports reached the peak of $X. From 2019 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

Australia dominates exports structure, reaching X tons, which was near 98% of total exports in 2022. New Zealand (X kg) followed a long way behind the leaders.

Exports from Australia decreased at an average annual rate of -4.4% from 2012 to 2022. New Zealand experienced a relatively flat trend pattern. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Australia ($X) remains the largest prophylactic medicaments containing insulin supplier in Australia and Oceania, comprising 92% of total exports. The second position in the ranking was held by New Zealand ($X), with a 6.1% share of total exports.

In Australia, prophylactic medicaments containing insulin exports shrank by an average annual rate of -5.4% over the period from 2012-2022.

Export Prices by Country

The export price in Australia and Oceania stood at $X per ton in 2022, increasing by 100% against the previous year. Over the period under review, the export price, however, saw a relatively flat trend pattern. The level of export peaked at $X per ton in 2018; however, from 2019 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was New Zealand ($X per ton), while Australia totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by New Zealand (+11.1%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Australia and Oceania

In 2022, after two years of decline, there was significant growth in overseas purchases of medicaments containing insulin but not antibiotics in measured doses, when their volume increased by 26% to X tons. Overall, imports, however, showed a slight setback. The volume of import peaked at X tons in 2016; however, from 2017 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports skyrocketed to $X in 2022. The total import value increased at an average annual rate of +1.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, imports hit record highs at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

Australia represented the major importer of medicaments containing insulin but not antibiotics in measured doses in Australia and Oceania, with the volume of imports reaching X tons, which was near 77% of total imports in 2022. It was distantly followed by New Zealand (X tons), creating a 21% share of total imports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into Australia stood at -3.6%. At the same time, New Zealand (+9.6%) displayed positive paces of growth. Moreover, New Zealand emerged as the fastest-growing importer imported in Australia and Oceania, with a CAGR of +9.6% from 2012-2022. New Zealand (+14 p.p.) significantly strengthened its position in terms of the total imports, while Australia saw its share reduced by -14.8% from 2012 to 2022, respectively.

In value terms, Australia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Australia and Oceania, comprising 77% of total imports. The second position in the ranking was taken by New Zealand ($X), with a 21% share of total imports.

In Australia, prophylactic medicaments containing insulin imports remained relatively stable over the period from 2012-2022.

Import Prices by Country

In 2022, the import price in Australia and Oceania amounted to $X per ton, almost unchanged from the previous year. Import price indicated a temperate increase from 2012 to 2022: its price increased at an average annual rate of +3.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by +2.0% against 2020 indices. The most prominent rate of growth was recorded in 2018 an increase of 45%. As a result, import price attained the peak level of $X per ton. From 2019 to 2022, the import prices remained at a lower figure.

Average prices varied noticeably amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was New Zealand ($X per ton), while Australia amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Australia (+3.2%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :